SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 33,114.56 |
Enterprise Value ($M) | 38,730.26 |
Book Value ($M) | 15,213.00 |
Book Value / Share | 104.49 |
Price / Book | 2.18 |
NCAV ($M) | -4,598.40 |
NCAV / Share | -31.58 |
Price / NCAV | -7.20 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.05 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | 0.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.32 |
Current Ratio | 2.10 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6,756.20 |
Assets | 26,567.60 |
Liabilities | 11,354.60 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 9,835.60 |
Operating Income | 1,895.00 |
Net Income | 1,161.10 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 1,547.20 |
Cash from Investing | -4,101.00 |
Cash from Financing | 149.30 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Primecap Management Co/ca/ | 11.22 | 3.59 | |
13G/A | Vanguard Group Inc | 10.02 | 21.25 | |
13G/A | BlackRock Inc. | 9.80 | -0.10 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
311,175 | 1,832,990 | 16.98 | |
144,398 | 944,543 | 15.29 | |
123,760 | 675,193 | 18.33 | |
122,659 | 670,028 | 18.31 | |
89,600 | 470,039 | 19.06 | |
(click for more detail) |
Similar Companies | |
---|---|
BCRX – BioCryst Pharmaceuticals, Inc. | BDTX – Black Diamond Therapeutics, Inc. |
BEAM – Beam Therapeutics Inc. | BLUE – bluebird bio, Inc. |
BMEA – Biomea Fusion, Inc. |
Financial data and stock pages provided by
Fintel.io